Market Strategy: Growth in Financials and Biotech

The video discusses the financial sector's growth potential amid changing interest rates, regulation, and tax cuts. It explores investment strategies, highlighting opportunities in healthcare and small caps. The discussion also covers market valuation, potential volatility, and the Fed's influence. The biotech sector's challenges and opportunities are examined, with a focus on drug pricing and market performance.

What is the significance of separating expectations from reality in the financial sector?

How have biotech companies responded to scrutiny on drug pricing?